Codexis, Inc. (FRA:4QK)
Germany · Delayed Price · Currency is EUR 1.461
-0.017 (-1.15%)
At close: Nov 28, 2025
Codexis Company Description
Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.
It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Codexis, Inc.
| Country | United States |
| Founded | 2002 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 188 |
| CEO | Alison Moore |
Contact Details
Address: 200 Penobscot Drive Redwood City, Delaware 94063 United States | |
| Phone | 650 421 8100 |
| Website | codexis.com |
Stock Details
| Ticker Symbol | 4QK |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Alison Moore | Chief Executive Officer |
| Georgia Erbez | Chief Financial Officer |
| Carrie McKim | Head of Investor Relations |